We tested the hypothesis that a prostanoid-mediated mechanism of vascular contraction is expressed in rats with aortic coarctation-induced hypertension. Rings of descending thoracic aorta taken from normotensive and hypertensive rats were contrasted in terms of constrictor responsiveness to arachidonic acid (AA), AA-induced release of eicosanoids, and ability to convert exogenous prostaglandin
(PG) H2 to PGI2. AA (10`8 to 10`mol/L) increased isometric tension in aortic rings (bathed in Krebs' bicarbonate buffer) of hypertensive but not normotensive rats. AA (10-5 mol/L) also elicited the release of PGI2, PGE2, thromboxane (TX) A2, and monohydroxyeicosatetraenoic acids (HETEs); this release from the aortic rings of hypertensive rats exceeded the corresponding release from the aortic rings of normotensive rats. However, the rate of conversion of exogenous PGH2 to PGI2 by aortic rings of hypertensive rats was <50% the rate of conversion by aortic rings of normotensive rats. The constrictor effect of AA in aortic rings of hypertensive rats was abolished by an hromboxane (TX) A2 and prostaglandin (PG) H2 stimulate contraction of vascular smooth muscle via interaction with a common receptor.1 Treatment with a blocker of TXA2-PGH2 receptors lowers the blood pressure of rats with established angiotensin II-and salt-induced hypertension2 and of rats in the early stage of the hypertension produced by complete ligation of the aorta between the renal arteries,3 a model of angiotensin-dependent hypertension. A blocker of TXA2-PGH2 receptors also was found to attenuate the constrictor effect of angiotensin II and calcium ionophore A23187 in rings of thoracic aorta taken from rats with aortic coarctation-induced hypertension but not from normotensive rats.45 From these findings, it was inferred that a pressor mechanism linked to the activation of TXA2-PGH2 receptors contributes to the increase in blood pressure and vascular contractility in angiotensin-dependent models of hypertension.2 5 The present study was designed to investigate whether a prostanoid-mediated mechanism of vascular contraction is hyperexpressed in rats with aortic coarctation-induced hypertension. To this end, rings of de-inhibitor of cyclooxygenase (indomethacin, 10 gmol/L) and a blocker of TXA2-PGH2 receptors (SQ29548, 1 ,umol/L) but was not affected by an inhibitor of TXA2 synthesis (CGS13080, 10 ,umol/L), suggesting mediation by PGH2. The lipoxygenase inhibitor baicalein (75 ,umol/L) also attenuated the constrictor effect of AA in aortic rings of hypertensive rats while decreasing the associated release of HETEs and correcting the impairment in the conversion of PGH2 to PGI2. We conclude that the expression of AA-induced PGH2-mediated constriction of aortic rings is increased in hypertensive rats because of increased PGH2 formation associated with disruption in the coupling of PGH2 synthesis to PGH2 metabolism caused by a product(s) of lipoxygenase with the ability to inhibit prostacyclin synthase. (Circ Res. 1994; 74:197-205.) Key Words * thromboxane-prostaglandin H2 receptors . hypertension * prostaglandin H2 * lipoxygenases * prostacyclin synthase scending thoracic aorta taken from normotensive and hypertensive rats were contrasted in terms of the effect of arachidonic acid on isometric tension development, the release of eicosanoids under basal conditions and after challenge with arachidonic acid, and the ability to convert exogenous PGH2 to PGI2. The effect of arachidonic acid on isometric tension was studied in the presence and absence of a cyclooxygenase inhibitor, a TX synthase inhibitor, a blocker of TXA2-PGH2 receptors, or an inhibitor of lipoxygenase(s).
Materials and Methods

Drugs and Solutions
Phenylephrine, acetylcholine, and indomethacin were obtained from Sigma Chemical Co, St Louis, Mo; arachidonic acid sodium salt, from Nu-Chek Laboratories, Elysian, Minn; PGH2, 15S-hydroxy-1 a,9a[epoxymethan]prosta-5Z-dienoic acid (U46619), 12(S)-hydroperoxyeicosa-5Z,8Z,1OE,14Z-tetraenoic acid (12- Stock solutions of arachidonic acid, CGS13080, and U51605 were prepared in 50 mmol/L Na2CO3; U46619 and SQ29548, in a mixture of ethanol and 50 mmol/L Na2CO3 (0.10:0.90 [vol/vol]); phenylephrine and acetylcholine, in distilled water; and CDC, PGE2, and PGD2, in ethanol. These solutions were aliquoted, stored at -70°C, and diluted further at the time of usage with Krebs' bicarbonate buffer. Stock solutions of 12-HpETE and 15-HpETE in Krebs' bicarbonate buffer, of baicalein in ethanol, of PGI2 in 50 mmol/L Na2CO3, and of PGH2 in 0.1 mol/L Tris-HCl (pH 7.4) were prepared immediately before usage. For PGH2, the concentration of the solution was verified by assay of PGF2< after reduction of PGH2 with SnCl2.67 The composition of Krebs' bicarbonate buffer was (mmol/L) NaCI, 118.5; KCl, 4.7; CaCl2, 2.8; KH2PO4, 1.2; MgSO4, 1.1; NaHCO3, 25.0; and dextrose, 11.1.
Animals
Experiments were conducted on male Sprague-Dawley rats (Charles River, Wilmington, Mass) weighing 300 to 325 g. Rats anesthetized with methoxyflurane (Pitmen-Moore, Inc, Washington Crossing, NJ) were subjected to aortic coarctation or sham aortic coarctation according to a published procedure.8 Briefly, the abdominal cavity was exposed through a midline incision, a silk ligature No. 000 was passed around the aorta at a point below the right renal artery and above the left renal artery, just below the origin of the superior mesenteric artery, and the aorta was either completely ligated or sham-ligated. On the day of the experiment, 7 to 12 days after aortic coarctation or 7 to 16 days after sham operation, the right carotid artery of rats anesthetized with sodium pentobarbital (50 mg/kg IP) was cannulated with polyethylene tubing (PE-50) connected to a pressure transducer (model P231D, Statham Division, Gould Inc, Oxnard, Calif) for recording of mean blood pressure on a polygraph (model 7D, Grass Instrument Co, Quincy, Mass). The blood pressure of rats 7 to 12 days after aortic coarctation was much higher than that of sham-operated rats (180+6 versus 102±2 mm Hg, P<.01). After blood pressure measurement, the thoracic cavity was exposed, and the descending thoracic aorta was excised, transferred to a dish filled with ice-cold Krebs' bicarbonate buffer, cleared of periadventitial tissue, and cut transversely into ring segments (3.0 mm in length). The aortic rings were used immediately in experiments to examine the effects of arachidonic acid and IXA2-PGH2 receptor agonist U46619 on isometric tension development and to evaluate the vascular release of eicosanoids and the ability to convert exogenous PGH2 to PGI2. Measurement of Isometric Tension in Rings of Aorta Each aortic ring was placed inside a water-jacketed 5-mL tissue bath filled with Krebs' bicarbonate buffer (37°C) bubbled with 95% 02-5% CO2 and attached to a force-displacement transducer (model FT03C, Grass) coupled to a polygraph (model 7D, Grass) for measurement of isometric tension as previously described.4 The rings of aorta were allowed to equilibrate at a resting tension of 2 g for 2 hours with changes of buffer at 15-minute intervals. Examination by light microscopy of selected aortic rings revealed that the endothelial lining was conserved after the experimental manipulations. The functionality of the endothelium was established by demonstrating that acetylcholine (10-6 mol/L) was effective in relaxing aortic rings precontracted by phenylephrine (5 x 10`mol/L). In some aortic ring preparations, the endothelium was removed by rubbing.
Experiments were initiated by obtaining in each aortic ring a reference contractile response to a maximally effective concentration of KCl (120 mmol/L). Subsequently, the rings were rinsed with Krebs' bicarbonate buffer several times, and once the tension had returned to baseline, the responsiveness to arachidonic acid or to other agonists was evaluated in the presence and/or absence of agents selected for their ability to block TXA2-PGH2 receptors or to inhibit selectively various enzymes involved in eicosanoid synthesis. Such agents were added to the tissue bath before obtaining the reference contractile response to 120 mmol/L KCl. The magnitude of agonist-induced contraction of aortic rings is expressed as the percentage of the reference contractile response to 120 mmol/L KCl. Aortic rings taken from sham-operated rats and from rats with aortic coarctation-induced hypertension were contrasted in terms of constrictor responsiveness to arachidonic acid (10`8 to 10`mol/L) added to the bath in a cumulative manner. This was complemented by examination of the effects of PGI2 (10-9 to 10-6 mol/L), PGE2 (10-9 to 10-6 mol/L), PGD2 (10`6 mol/L), PGH2 (10`mol/L), 12-HETE (10`mol/L), 15 -HETE (10-5 mol/L), and U46619 (10-9 to 10-6 mol/L), a synthetic agonist for TXA2-PGH2 receptors, on the tone of aortic rings taken from hypertensive and shamoperated normotensive rats.
The effect of arachidonic acid on tension development by aortic rings taken from sham-operated rats was studied in the absence and presence of U51605 (0.5 ,umol/L) to inhibit prostacyclin synthase,9 12-HpETE (10 ,umol/L), or 15-HpETE (10 ,umol/L). The effect of arachidonic acid on tension development by aortic rings obtained from hypertensive rats was studied in the absence and presence of indomethacin (10 gmol/L) to inhibit cyclooxygenase,0 CGS13080 (10 gmol/L) to inhibit thromboxane synthase,"1 SQ29548 (1 ,umol/L) to block TXA2-PGH2 receptors,'2 baicalein (75 ,umol/L) or CDC (10 ,umol/L) to inhibit lipoxygenase(s),'3,14 and U51605 (0.5 ,umol/L). The effectiveness of SQ29548 (1 ,umol/L) to block the contraction of aortic rings elicited by the activation of TXA2-PGH2 receptors with U46619 was documented previously. 4, 7 The contractile response to U46619 (10-9 to 10`6 mol/L) in aortic rings of hypertensive rats was examined in the absence and presence of baicalein (75 ,mol/L) or CDC (10 ,umol/L); the response in aortic rings from sham-operated rats was studied in the absence and presence of U51605 (0.5 gmol/L), 15 -HpETE (10 ,umol/L), or 12-HpETE (10 ,umol/L). The contractile response to PGH2 in aortic rings of normotensive and hypertensive rats was examined in the absence and presence of baicalein (75 ,umol/L).
Measurement of Eicosanoid Release in Rings of Aorta
Rings of aorta obtained from sham-operated rats and rats with aortic coarctation-induced hypertension were compared in terms of release of prostanoids and monohydroxyeicosatetraenoic acids (HETEs). Aortic rings were placed in 20-mL flasks containing Krebs' bicarbonate buffer (2.0 mL) with and without arachidonic acid (10 ,umol/L) and were incubated for 15 minutes at 37°C in an atmosphere of 95% 02-5% CO2 and agitated at 100 cycles per minute. In some experiments, the aortic rings were preincubated for 15 minutes in media with and without indomethacin (10 ,.tmol/L), CGS13080 (10 Lmol/ L), baicalein (75 gmol/L), or U51605 (0.5 lumol/L) and subsequently were transferred to flasks containing media (2.0 mL) with arachidonic acid (10 ,umol/L) for incubation (15 minutes, 37°C) in the presence and absence of the aforementioned enzyme inhibitors.
The amount of PGI2 (measured as 6-keto-PGF,J), TXA2
(measured as TXB2), and PGE2 released into the medium was measured as previously described by enzyme immunoassay of unextracted samples using reagents purchased from Cayman.25
The results are expressed as picomoles of prostanoid released during the 15-minute incubation period per milligram of dry tissue. Neither PGI2 nor TXA2 or PGE2 could be detected in control incubations consisting of Krebs' bicarbonate buffer with and without arachidonic acid (10 ,mol/L) alone or with aortic rings denatured by heating at 100°C for 5 minutes.
The amount of HETEs released into the medium was measured by gas chromatography-mass spectrometry. To this end, an internal standard [50 ng 12(S)-HETE-d8] was added to each sample, which then was acidified (pH 3.5) with formic acid and extracted with ethyl acetate. The organic phase of the mixture was dried under a stream of nitrogen, and the residue was dissolved in acetonitrile (100 tL) and reacted with pentafluorobenzyl bromide (PFB, 10 ,uL) and diisopropylethylamine (10 ,uL) for 30 minutes at room temperature.16 Samples were then dried under nitrogen, and the residue was dissolved in methanol (50 ,L), applied to Silica Gel 60 A plates (LK6D, Whatman, Maidstone, UK), and chromatographed using hexane and ethyl acetate (3:1 [vol/vol]) as a solvent system. A mixture of 12(S)-HETE-d8 (50 ng) and [3H]12(S)-HETE (4 ,Ci, Du Pont NEN Research Products, Boston, Mass) also was treated with PFB and diisopropylethylamine, and the resulting PFB-ester derivatives were chromatographed concurrently with the experimental samples. The chromatography plate was scanned for radioactivity to identify the position of the tritium-labeled PFB-ester of 12(S)-HETE. For experimental samples, the area of the plate corresponding to the position of PFB-derivatized 12(S)-HETE was scraped, and lipids were extracted with ethyl acetate and water (1 :0.1 [vol/vol]). The extracts were dried under nitrogen, and the residue was reacted with 80 ,L of N,O-bis(trimethylsilyl)trifluoroacetamide (Pierce, Rockford, Ill) for 30 minutes at 700C.16 Just before analysis, the samples were dried, and the residue was dissolved in 5 ,uL octane.
The trimethylsilyl ether-PFB derivatives of 12(S)-HETE and other HETEs were analyzed by capillary-column gas chromatography on a Hewlett-Packard 5890 gas chromatograph interfaced with a Hewlett-Packard 5989A quadrupole mass spectrometer. Samples were injected into an SP-2330 capillary gas chromatography column (length, 15 m; inner diameter, 0.25 mm; and film thickness, 0.2 gm; Supelco, Bellefonte, Pa). The operating temperature was 200°C for the injector and 280°C for the transfer line. The oven temperature was programmed from 100°C to 300°C at 25°C/min. Helium was used as the carrier gas. The samples were mass-analyzed via the negative-ion chemical ionization mode at the electron energy of 150 eV and methane pressure of 1 mm Hg. Ions at mass to charge ratios of 391 and 399, corresponding to endogenous HETEs and the deuterated internal standard, respectively, were selectively monitored, and the ratio of ions was measured for each experimental sample and concentration of 12(S)-HETE in the standard curve. Since under our experimental conditions gas chromatography did not resolve 12(S)-HETE from other HETEs, the results represent total release of HETEs during the 15-minute incubation period per milligram of dry tissue. No HETEs could be detected in control incubations consisting of Krebs' bicarbonate buffer with and without arachidonic acid (10 gLmol/L) alone or with aortic rings denatured by heating at 100°C for 5 minutes.
Measurement of Conversion of PGH2 to PGI2 by Aortic Rings
Rings of aorta obtained from sham-operated rats and rats with aortic coarctation-induced hypertension were preincubated for 20 minutes at 37°C in Krebs' bicarbonate buffer equilibrated with 95% 02-5% C02 and containing indomethacin (10 ,umol/L) to inhibit cyclooxygenase. The rings were then transferred to 20-mL flasks containing fresh buffer (2.0 mL) for incubation at 37°C for 3 minutes in the presence and absence of exogenous PGH2 (1 gmol/L). In some experiments, the buffer used for the preincubation and incubation periods also contained (gmol/L) baicalein, 75; CDC, 10; 12-HpETE, 10; 15-HpETE, 10; or U51605, 0.5. The concentration of 6-keto-PGFia in the incubation media was measured by enzyme immunoassay of unextracted samples.'5 The concentration of 6-keto-PGF,a in media derived from incubation of aortic rings in indomethacin-containing buffer without exogenous PGH2 was <3% of the concentration in media derived from incubations carried out in the presence of exogenous PGH2. Hence, at least 97% of the 6-keto-PGFia in the incubation media with PGH2 arises from exogenous PGH2. Results of the conversion of PGH2 to PGI2 are expressed as picomoles of 6-keto-PGF,a formed during the 3-minute incubation period per milligram of dry tissue. No conversion of exogenous PGH2 to PGI2 could be detected in control incubations using aortic rings denatured by heating at 100°C for 5 minutes. Consequently, when cyclooxygenase is inhibited by indomethacin, the conversion of exogenous PGH2 to PGI2 by aortic rings reflects the tissue activity of prostacyclin synthase.
Statistical Analysis
Results are expressed as mean±SEM. Data were analyzed as appropriate by Student's t test or by an ANOVA followed by the Newman-Keuls a posteriori test. The null hypothesis was rejected at P<.05. Fig 1 depicts the effect of arachidonic acid and TXA2-PGH2 receptor agonist U46619 on isometric tension development in rings of descending thoracic aorta taken from sham-operated normotensive rats and rats with aortic coarctation-induced hypertension. KCl (120 mmol/L) elicited nearly identical increases of isometric tension in aortic rings of normotensive (1.45 ±0.6 g) and hypertensive (1.43+±0.08 g) rats. Arachidonic acid (10`8 to 10-5 mol/L) caused contraction of aortic rings taken from rats with aortic coarctation-induced hypertension but elicited little or no contractile response in aortic rings taken from sham-operated normotensive control rats. U46619 (10-9 to 10-6 mol/L) elicited similar constrictor responses in aortic rings of normotensive and hypertensive rats. Constrictor responses to PGH2 (10-7 mol/L) were greater in aortic rings of hypertensive (n=8) than of normotensive (n=6) rats (42+6% versus 20+5% of response to 120 mmol/L KCl, P<.05). PGE2 at 10`6 mol/L elicited similar constrictor responses in aortic rings of normotensive (n=4) and hypertensive (n=4) rats (13±6% versus 17±5% of response to 120 mmol/L KCl) but was without constrictor effect at lower concentrations. Neither PGI2 (10-9 to 10-6 mol/L), PGD2 (10-6 mol/L), 12-HETE (10-5 mol/L), nor 15-HETE (10-5 mol/L) affected the tone of aortic rings from either normotensive (n=4) or hypertensive (n=4) rats. In aortic rings taken from rats with aortic coarctation-induced hypertension, constrictor responses to arachidonic acid (10-5 mol/L) in preparations denuded of endothelium (n=9) surpassed the responses in preparations with intact endothelium (n=9) (132±26% versus 81±13% of response to 120 mmol/L KCl, P<.05); constrictor responses to PGH2 (10-7 mol/L) also were greater in rings without endothelium (n=5) than in rings with endothelium (n=5) (55±9% versus 32±4% of response to 120 mmol/L KCl, P<.05). (TXB2), and monohydroxyeicosatetraenoic acids (HETEs) from rings of descending thoracic aorta incubated for 15 minutes at 370C in Krebs' bicarbonate buffer with and without arachidonic acid (10 ,umol/L). Aortic rings were obtained from sham-operated normotensive rats and from rats with aortic coarctationinduced hypertension. The values illustrated are mean+SEM; n indicates the number of rats. *P<.05 relative to data for rings from normotensive rats; tP<.05 relative to data for corresponding rings incubated without arachidonic acid. 120 mmol/L KCl (n=7, P<.05). The constrictor effect of PGH2 (10`mol/L) in aortic rings of sham-operated normotensive rats was not altered by baicalein (75 ,umol/L, 17±5% versus 16±2% of response to 120 mmol/L KCl, n=3). (Fig 5) . Baicalein also decreased the associated release of PGE2 while increasing that of PGI2 ( Fig 5) . The arachidonic acid-induced release of TXA2 from aortic rings of hypertensive rats was reduced selectively by CGS13080 (10 ,umol/L, 0.40±0.4 versus 0.17±0.01 pmol/mg dry tissue, P<.05).
Results
As shown in
Aortic rings from normotensive rats and rats with aortic coarctation-induced hypertension differ from each other not only in terms of eicosanoid release and the effect of arachidonic acid on isometric tension but also in their ability to metabolize exogenous PGH2 to PGI1 during short-term incubation in media containing indomethacin to suppress cyclooxygenase. This is illustrated in Fig 6, which shows that rings of aorta taken from hypertensive rats converted exogenous PGH2 to PGI2 at less than one half (P<.01) the rate of conversion by aortic rings of normotensive control rats. This impairment in metabolism of exogenous PGH2 to PGI2 by aortic rings of hypertensive rats was corrected by the lipoxygenase inhibitors baicalein (75 gmol/L) and CDC (10 ,umol/L), which increased the conversion rate of PGH2 to PGI2 by threefold to fourfold, to the level found in aortic rings taken from normotensive rats (Fig  7) . However, neither lipoxygenase inhibitor affected the conversion rate of exogenous PGH2 to PGI2 by aortic rings of normotensive rats (Fig 7) . As shown in and 15 -HpETE (10 g.mol/L), respectively, reduced to <50% of control (P<.05) the conversion of exogenous PGH2 to PGI2 by aortic rings taken from normotensive and hypertensive rats. In aortic rings of normotensive rats, the conversion rate of PGH2 to PGI2 measured after preincubation (20 minutes) with 12-HpETE (10 ,mol/L, 5.7±0.7 pmol 6-keto-PGFl, per milligram for 3 minutes, n=7) was comparable to that after concurrent preincubation with 12-HpETE (10 ,umol/L) and baicalein (75 ,umol/L, 5.3±0.6 pmol 6-keto-PGF,a per milligram for 3 minutes, n=7) but was exceeded (P<.05) by that measured after rings preincubated with 12-HpETE (10 ,umol/L) were successively washed and incubated (20 minutes) again in fresh Krebs' bicarbonate buffer (9.7±1.1 pmol 6-keto-PGFia per milligram for 3 minutes, n=7). synthetic inhibitor of prostacyclin synthase, on constrictor responses to arachidonic acid (10-5 mol/L) and U46619 (10-7 mol/L) in rings of aorta taken from normotensive rats. The tone of quiescent rings of aorta was not affected by the addition of 12-HpETE, 15- HpETE, or U51605 to the tissue bath. Neither agent affected the constrictor response to U46619. However, exposure of aortic rings to 12-HpETE, 15-HpETE, or U51605 greatly increased the constrictor response to arachidonic acid. U51605 (0.5 gmol/L) also increased the constrictor effect of arachidonic acid (10`mol/L) in aortic rings of rats with aortic coarctation-induced hypertension (from 39±5% to 59±10% of the response to 120 mmol/L KCI, n=7, P<.05). The constrictor response to arachidonic acid (10-5 mol/L) in aortic rings of normotensive rats bathed in media containing U51605 (0.5 gmol/L) was not affected by the thromboxane synthase inhibitor CGS13080 (10 ,umol/L, 51±7% versus 50±8% of response to 120 mmol/L KCI, n=4) but was completely inhibited by the TXA2-PGH2 receptor blocker SQ29548 (1 ,umol/L). Discussion
The central finding of the present study is that arachidonic acid stimulates tension development in rings of descending thoracic aorta taken from rats with aortic coarctation-induced hypertension but has little or no effect on tension development in aortic rings taken from sham-operated normotensive rats. That the constrictor effect of arachidonic acid in aortic rings of hypertensive rats is blunted by indomethacin and SQ29548, an inhibitor of prostanoid synthesis and a blocker of TXA2-PGH2 receptors, respectively, indicates that the effect is mediated by a prostanoid(s) that contracts vascular smooth muscle via interaction with TXA2-PGH2 receptors. Consequently, the finding of increased constrictor responsiveness to arachidonic acid in aortic rings of rats with aortic coarctation-induced hypertension is evidence that a prostanoid-mediated mechanism of vascular contraction is hyperexpressed in this model of hypertension. Previous studies also sug- *P<.05 relative to data for rings exposed to vehicle only. gest that a mechanism of vasoconstriction mediated by TXA2 and/or PGH2 is activated in other models of experimental hypertension'7"18 and renal disease'9 and in response to hypercholesterolemia20 and agonists.21
Hyperexpression of vasoconstrictor mechanisms mediated by prostanoids may be the result of increased vascular smooth muscle responsiveness to constrictor prostanoids, elevated tissue levels of constrictor prostanoid(s), or both abnormalities combined. In the present study, the increased expression of prostanoidmediated constrictor responses to arachidonic acid in aortic rings of rats with aortic coarctation-induced hypertension was associated with increased constrictor responsiveness to PGH2, the immediate precursor of TXA2 and prostaglandins. This increased constrictor responsiveness cannot be ascribed to a primary en- data for rings not exposed to 12-HpETE or U51605. _ hancement of aortic smooth muscle responsiveness to agonists for TXA2-PGH2 receptors, since direct activation of such receptors with U46619, a stable analogue of PGH2, elicited similar constrictor responses in aortic rings of normotensive and hypertensive rats. Rather, the increase in constrictor responsiveness to PGH2 in aortic rings of hypertensive rats may be linked to the observation that such rings are impaired in their ability to metabolize PGH2 to PGI2. Recent reports have implicated PGH2 in the mediation of constrictor responses to arachidonic acid in the rabbit aorta,7 to acetylcholine and serotonin in the aorta of spontaneously hypertensive rats, 22 24 and to angiotensin II and calcium ionophore A23187 in the aorta of rats with aortic coarctation-induced hypertension.4'5 In the present study, a role for PGH2 in the implementation of arachidonic acid-induced contraction of aortic rings from hypertensive rats is inferred from the finding that the constrictor effect of the fatty acid, which is not attenuated by inhibition of thromboxane synthase, is virtually obliterated by the blockade of TXA2-PGH2 receptors. A role for increased TXA2 levels in the implementation of arachidonic acid-induced contraction of aortic rings from hypertensive rats is unlikely, since inhibition of TX synthase with CGS13080 did not interfere with the constrictor effect of arachidonic acid.
The level of PGH2 in vascular tissues is determined by the balance between the rates of PGH2 synthesis and PGH2 metabolism. In the aorta and other arterial vessels, PGH2 is metabolized primarily by prostacyclin synthase to yield PG1225,26; metabolic conversion of PGH2 to other prostanoids also occurs but is relatively minor and, in the case of conversion to PGE2, may be nonenzymatic. 26 The present study demonstrates that aortic rings from hypertensive rats are impaired in their ability to convert exogenous PGH2 to PGI2. The study also demonstrates that the release of PGI2, PGE2, and TXA2 elicited by arachidonic acid from aortic rings of hypertensive rats exceeds the corresponding release from aortic rings of normotensive control rats. Since all these prostanoids are derived from PGH2, the results imply that the production of PGH2 by aortic rings exposed to arachidonic acid is increased in rats with aortic coarctation-induced hypertension. It is intriguing that the aortic rings of hypertensive rats release more PGI2 than do the aortic rings from normotensive control rats despite having a diminished ability to metabolize exogenous PGH2 to PGI2. A tentative interpretation of these observations, assuming that the intracellular concentration of PGH2 is well below that required for prostacyclin synthase to operate at maximum velocity, is that the increased release of PGH2 in aortic rings of hypertensive rats is driven by the enhanced production of PGH2. The association of increased PGH2 synthesis and impaired ability to metabolize PGH2 to PGI2 in aortic rings of hypertensive rats may be expected to intensify the arachidonic acid-induced elevation of PGH2 levels, with attendant augmentation in constrictor responsiveness to the fatty acid.
Arterial vessels and cultured smooth muscle and endothelial cells are known to metabolize arachidonic acid to monohydroxylated products, primarily 12-HETE and 15-HETE. [27] [28] [29] The present study demon-hypertension release more HETEs than do aortic rings taken from normotensive rats. This is in general agreement with a report that the production of 12-HETE by aortic tissue is increased in rats with renovascular hypertension. 30 The synthesis of 12-HETE and 15-HETE involves stereospecific lipoxygenases that catalyze the conversion of arachidonic acid to 12-HpETE and 15-HpETE, respectively, unstable intermediates that are subsequently reduced spontaneously or by the action of peroxidases to the corresponding HETE.3' 15-HETE also arises in some blood vessels via metabolism of arachidonic acid by cyclooxygenase. 32 The present study suggests that lipoxygenase(s) rather than cyclooxygenase catalyzes the synthesis of HETEs released from aortic rings of hypertensive rats in response to arachidonic acid, since the release was greatly diminished by baicalein, an inhibitor of lipoxygenase(s). 13 The observation that arachidonic acid-induced release of HETEs from aortic rings is increased in rats with aortic coarctation-induced hypertension fosters the notion that the activity of vascular lipoxygenase(s) is enhanced in this model of angiotensin-dependent hypertension. Relative to this point, angiotensin II has been reported to increase the expression of 12-lipoxygenase protein and mRNA in porcine aortic smooth muscle cells, as well as to stimulate the production of 12-HETE and 15-HETE. 33 According to the present study, the status of lipoxygenase may influence the conversion of PGH2 to PGI2 in aortic rings of rats with aortic coarctation-induced hypertension. This is inferred from observations that the conversion of PGH2 to PGI2 by aortic rings of hypertensive rats was increased by threefold to fourfold on exposure to chemically dissimilar inhibitors of lipoxygenase(s), baicalein and CDC, bringing it up to the rate of conversion found in aortic rings of normotensive rats. It is unlikely that baicalein or CDC stimulates prostacyclin synthase directly, since neither agent increased the conversion of PGH2 to PGI2 by aortic rings of normotensive rats. Rather, the stimulatory effect of these agents on conversion of PGH2 to PGI2 by aortic rings of hypertensive rats may be secondary to interference with lipoxygenase-catalyzed synthesis of an inhibitor of prostacyclin synthase. If so, the impairment in ability to convert PGH2 to PGI2 in aortic rings taken from rats with aortic coarctation-induced hypertension may be a consequence of inhibition of prostacyclin synthase by a product of lipoxygenase activity. In this regard, we found that both 12-HpETE and 15-HpETE inhibited the conversion of exogenous PGH2 to PGI2 by aortic rings. Previous studies also documented that prostacyclin synthase is inhibited by 12-HpETE, 15-HpETE, and other hydroperoxides derived from linoleic acid, y-linolenic acid, and dihomo-y-linolenic acid via metabolism by lipoxygenase(s).26,34-36 Hence, endogenous hydroperoxides arising from arachidonic acid or from other polyunsaturated fatty acids are candidates for mediating the impairment in PGH2 conversion to PGI2 in aortic rings of hypertensive rats. Such a notion as it relates to 12-HpETE and 15 -HpETE may be challenged because the formation of hydroperoxides of arachidonic acids as estimated by the release of HETEs was not detectable in aortic rings incubated strates that after exposure to arachidonic acid aortic rings taken from rats with aortic coarctation-induced without exogenous arachidonic acid. However, since HETEs are efficiently incorporated into cell phospho-lipids,37 it may be argued that the failure to detect release of HETEs does not signify that the corresponding hydroperoxide precursors are not formed.
Products of lipoxygenase with an ability to inhibit prostacyclin synthase are expected to disrupt the coupling between vascular PGH2 synthesis by cyclooxygenase and PGH2 metabolism by prostacyclin synthase and, consequently, cause amplification of vasoconstrictor responses mediated by PGH2. The validity of this prediction is supported by the demonstration that the constrictor effect of arachidonic acid in aortic rings of normotensive rats was greatly enhanced by 12-HpETE, 15 -HpETE, and U51605, a synthetic inhibitor of prostacyclin synthase. 9 Conversely, in aortic rings of hypertensive rats, the constrictor effect of arachidonic acid, which is overexpressed and associated with increased release of lipoxygenase products, was greatly attenuated by the lipoxygenase inhibitors baicalein and CDC. That the constrictor response of aortic rings to U46619induced activation of TXA2-PGH2 receptors was not affected by either the HpETEs or the lipoxygenase inhibitors suggests specificity in the effects of these agents on arachidonic acid-induced vascular contraction. In aortic rings of normotensive rats, amplification of the constrictor response to arachidonic acid by the HpETEs and U51605 is attributable to intensification of the associated rise in PGH2 caused by attenuation of PGH2 conversion to PGI2. On the other hand, in aortic rings of rats with aortic coarctation-induced hypertension, inhibition of the constrictor response to arachidonic acid by baicalein and CDC may be ascribed to inhibition of the associated rise in PGH2, prompted by an increased conversion of PGH2 to PGI2 due to the decreased synthesis of lipoxygenase products with an ability to inhibit prostacyclin synthase.
All in all, the present study in rats with aortic coarctation-induced hypertension suggests that the augmented expression of arachidonic acid-induced PGH2mediated constriction of aortic rings is largely the functional manifestation of increased PGH2 formation associated with disruption in the coupling of PGH2 synthesis to PGH2 metabolism that is caused by a product(s) of lipoxygenase with the ability to inhibit prostacyclin synthase. This conclusion may or may not apply to resistance arterial vessels of hypertensive rats. If it does, consideration should be give to the possibility that excessive vascular production of lipoxygenase products contributes to the increase in blood pressure by fostering the expression of a vasoconstrictor mechanism mediated by PGH2. A role for products of arachidonic acid metabolism by lipoxygenase in the pathogenesis of hypertension was first suggested by a report that the blood pressure of rats with two-kidney, one-clip hypertension falls with the administration of an inhibitor of lipoxygenase.30
